White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool

Hopper, A.D., Cross, S.S., Hurlstone, D.P., McAlindon, M.E., Lobo, A.J., Hadjivassiliou, M., Sloan, M.E., Dixon, S. and Sanders, D.S. (2007) Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ, 334 (7596). p. 729. ISSN 0959-8146

Full text not available from this repository.

Abstract

Objective: To determine an effective diagnostic method of detecting all cases of coeliac disease in patients referred for gastroscopy without performing routine duodenal biopsy.

Design: An initial retrospective cohort of patients attending for gastroscopy was analysed to derive a clinical decision toot that could increase the detection of coeliac disease without performing routine duodenal biopsy. The toot incorporated serology (measuring antibodies to tissue transglutaminase) and stratifying patients according to their referral symptoms (patients were classified as having a "high risk" or "low risk" of coeliac disease). The decision tool was then tested on a second cohort of patients attending for gastroscopy. In the second cohort all patients had a routine duodenal biopsy and serology performed.

Setting: Teaching hospital in Sheffield.

Participants: 2000 consecutive adult patients referred for gastroscopy recruited prospectively.

Main outcome measure: Evaluation of a clinical decision toot using patients' referral symptoms, tissue transglutaminase antibody results, and duodenal biopsy results.

Results: No cases of coeliac disease were missed by the pre-endoscopy testing algorithm. The prevalence of coeliac disease in patients attending for endoscopy was 3.9% (77/2000, 95% confidence interval 3.1% to 4.8%). The prevalence in the high risk and low risk groups was 9.6% (71/739, 7.7% to 12.0%) and 0.5% (6/1261, 0.2% to 1.0%). The prevalence of coeliac disease in patients who were negative for tissue transglutaminase antibody was 0.4% (7/2000). The sensitivity, specificity, positive predictive value, and negative predictive value for a positive antibody result to diagnose coeliac disease was 90.9%, 90.9%, 28.6%, and 99.6%, respectively. Evaluation of the clinical decision toot gave a sensitivity, specificity, positive predictive value, and negative predictive value of 100%, 60.8%, 9.3%, and 100%, respectively.

Conclusions: Pre-endoscopy serological testing in combination with biopsy of high risk cases detected all cases of coeliac disease. The use of this decision toot may enable the endoscopist to target patients who need a duodenal biopsy.

Item Type: Article
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Repository Officer
Date Deposited: 03 Nov 2008 19:12
Last Modified: 03 Nov 2008 19:12
Published Version: http:dx.doi.org/10.1136/bmj.39133.668681.BE
Status: Published
Publisher: BMJ Publishing
Refereed: Yes
Identification Number: 10.1136/bmj.39133.668681.BE
URI: http://eprints.whiterose.ac.uk/id/eprint/4819

Actions (login required)

View Item View Item